Immucell (ICCC) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to -$0.02.
- Immucell's EPS (Weighted Average and Diluted) rose 7777.78% to -$0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.28, marking a year-over-year increase of 15600.0%. This contributed to the annual value of -$0.26 for FY2024, which is 6511.62% up from last year.
- As of Q3 2025, Immucell's EPS (Weighted Average and Diluted) stood at -$0.02, which was up 7777.78% from $0.06 recorded in Q2 2025.
- Over the past 5 years, Immucell's EPS (Weighted Average and Diluted) peaked at $0.16 during Q1 2025, and registered a low of -$0.3 during Q1 2023.
- Over the past 5 years, Immucell's median EPS (Weighted Average and Diluted) value was -$0.06 (recorded in 2021), while the average stood at -$0.06.
- As far as peak fluctuations go, Immucell's EPS (Weighted Average and Diluted) crashed by 230540.45% in 2022, and later skyrocketed by 36666.67% in 2025.
- Immucell's EPS (Weighted Average and Diluted) (Quarter) stood at $0.01 in 2021, then crashed by 2305.4% to -$0.22 in 2022, then soared by 31.68% to -$0.15 in 2023, then skyrocketed by 154.38% to $0.08 in 2024, then plummeted by 125.0% to -$0.02 in 2025.
- Its last three reported values are -$0.02 in Q3 2025, $0.06 for Q2 2025, and $0.16 during Q1 2025.